New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 24, 2014
10:01 EDTAMBA, DSGX, PETX, HCLP, OIIM, NGHC, RXDX, TMUS, ADNC, NCS, QUNR, RESI, ABMD, CLVS, CECEOn The Fly: Analyst Initiation Summary
Abiomed (ABMD) initiated with an Outperform at Leerink... CECO Environmental (CECE) initiated with a Hold at Jefferies... Clovis (CLVS) initiated with a Neutral at Goldman... Descartes Systems (DSGX) initiated with an Outperform at Raymond James... NCI Building Systems (NCS) initiated with an Outperform at Credit Suisse... National General (NGHC) initiated with an Outperform at FBR Capital... Ambarella (AMBA) initiated with a Buy at Topeka... Audience (ADNC) initiated with a Buy at Topeka... O2Micro (OIIM) initiated with an Outperform at Northland Securities... Altisource Residential (RESI) initiated with a Buy at Compass Point... T-Mobile (TMUS) initiated with an Equal Weight at Evercore... Qunar (QUNR) initiated with a Neutral at Macquarie... Hi-Crush Partners (HCLP) initiated with a Buy at Ladenburg... Ignyta (RXDX) initiated with a Buy at Ladenburg... Aratana Therapeutics (PETX) initiated with a Buy at Jefferies.
News For ABMD;CECE;CLVS;DSGX;NCS;NGHC;AMBA;ADNC;OIIM;RESI;TMUS;HCLP;QUNR;RXDX;PETX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
March 23, 2015
19:13 EDTABMDOn The Fly: After Hours Movers
Subscribe for More Information
17:47 EDTABMDAbiomed confirms FDA approval of Impella 2.5 heart pump
Subscribe for More Information
17:17 EDTABMDFDA approves Impella 2.5 System
The U.S. FDA approved the Impella 2.5 System, a miniature blood pump system intended to help certain patients maintain stable heart function and circulation during certain high-risk percutaneous coronary intervention procedures, such as balloon angioplasty and stenting, which re-open coronary arteries that are narrowed or blocked due to severe coronary artery disease. The Impella 2.5 System is manufactured by Abiomed, based in Danvers, Massachusetts. Reference Link
March 20, 2015
09:36 EDTAMBAAmbarella management to meet with Needham
Meetings to be held in Boston on March 24 and in New York on March 25 hosted by Needham.
07:30 EDTHCLPHi-Crush Partners volatility at eight-month lows
Subscribe for More Information
06:32 EDTTMUST-Mobile employment policies struck down by judge, NY Times says
Subscribe for More Information
March 19, 2015
07:33 EDTTMUST-Mobile well-positioned to take share in business market, says Pacific Crest
After T-Mobile said it was bringing its Unicarrier programs to the workplace, Pacific Crest believes that the company's low business market share, positive brand image and consumer momentum position it well to take share from incumbents. The firm keeps an Outperform rating on the shares.
07:17 EDTABMDStephens to hold a conference
Subscribe for More Information
March 18, 2015
13:59 EDTTMUST-Mobile announces 'Un-contract,' 'Carrier Freedom' initiatives
Today, during an event held to announce Un-carrier 9.0 − Un-carrier for Business − T-Mobile (TMUS) unveiled two new major Un-carrier initiatives for consumers. First, with T-Mobile’s new "Un-contract," customers will now have more certainty in their wireless pricing than ever before. Consumers and businesses with the Simple Choice rate plan will find that rates won’t go up as long as they’re a T-Mobile customer and keep their plan − and even customers with unlimited 4G LTE will lock in their rates for a minimum of two years. The Un-carrier also launched "Carrier Freedom," a new move where T-Mobile will now cover all outstanding phone and tablet payments up to $650 per line when customers from AT&T (T), Verizon (VZ) or Sprint (S) switch to T-Mobile.
11:36 EDTRXDXIgnyta price target raised to $17 from $14 at Leerink
Subscribe for More Information
07:02 EDTNCSExterran nominates five new directors to board
Exterran Holdings (EXH) announced that its Board of Directors has nominated the following individuals for election to the Exterran Holdings Board at the Company’s 2015 Annual Meeting of Stockholders on April 28: Anne-Marie N. Ainsworth – former President and CEO of the general partner of Oiltanking Partners, L.P. (OILT); Frances Powell Hawes – independent financial consultant and former CFO of NCI Building Systems (NCS); James H. Lytal – independent energy consultant and former President of Gulfterra Energy Partners LP; Richard R. Stewart- former President and CEO of GE Aero Energy (GE); and Ieda Gomes Yell – Managing Director of Energix Strategy Ltd. and former President of BP Brazil (BP). “In November 2014, we announced a plan to separate Exterran’s international contract operations, international aftermarket services and global fabrication businesses into an independent, publicly traded company in the second half of 2015,” said Mark Sotir, Executive Chairman of the Board. “Our Board has nominated these additional well qualified director candidates in anticipation of certain of Exterran’s directors resigning from the Board at the time of the separation in order to join the board of directors of the new publicly traded company. We have not yet reached a final determination regarding which directors will remain on Exterran’s Board and which directors will join the board of directors of SpinCo at the time of the separation.”
March 17, 2015
19:42 EDTRXDXOn The Fly: After Hours Movers
Subscribe for More Information
16:55 EDTCECECECO Environmental files to delay Form 10-K
Subscribe for More Information
16:03 EDTRXDXIgnyta acquires 4 oncology R&D assets from Teva for 1.5M shares of common stock
Teva (TEVA) and Ignyta (RXDX) announced the acquisition by Ignyta of the worldwide rights and assets relating to four targeted oncology development programs in exchange for 1.5M shares of Ignyta’s common stock. Concurrently, Ignyta has entered into stock purchase agreements with Teva, and selected additional healthcare investors, whereby Teva will purchase a further 1.5 million shares of common Ignyta stock at a price of $10 per share in a registered direct offering. The other investors will purchase an additional 2.7M shares at $10 per share, valuing the total offering at approximately $41.6M. Under the terms of the asset purchase agreement with Teva, Ignyta is acquiring all of Teva’s assets and worldwide rights relating to four oncology development programs in exchange for 1.5M shares of Ignyta’s common stock. Teva has agreed not to sell or otherwise transfer any of these shares until March 17, 2016, and Ignyta is required to register the resale of these shares with the SEC prior to such date. Ignyta also assumed all of Teva’s ongoing obligations under certain contracts relating to the purchased programs, including the agreements under which Teva in-licensed rights to the assets.
09:45 EDTQUNRQunar upgraded to Overweight from Neutral at HSBC
09:04 EDTTMUST-Mobile offers data rollover to prepaid customers
In a blog post Monday, T-Mobile Chief Marketing Officer Andrew Sherrard stated "This month, we’re taking Data Stash even further. Starting Sunday March 22, Data Stash will start rolling out to Simple Choice prepaid customers. Every single one of our prepaid voice customers with a qualifying Simple Choice plan will start out with a Starter Stash with up to 10 GB of 4G LTE data. And when that’s all used up, they’ll start rolling forward their unused data for use up to a full year. Automatically and at no extra charge... Last year, wireless customers asked to keep their unused data more than 40,000 times − and that was just on Twitter alone." Reference Link
07:55 EDTTMUST-Mobile to hold a meeting
Subscribe for More Information
March 16, 2015
19:00 EDTQUNROn The Fly: After Hours Movers
Subscribe for More Information
17:04 EDTQUNRQunar reports Q4 EPS (90c), consensus (45c)
Reports Q4 revenue $83.8M, consensus $79.45M.
11:04 EDTNGHCNational General management to meet with William Blair
Meetings to be held in Europe March 18-20 hosted by William Blair.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use